3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Breast
1
Conditions
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Interventions
fludarabine
63
Cyclophosphamide
63
venetoclax
57
Azacitidine
52
fludarabine phosphate
50
Specimen Handling
43
Whole-Body Irradiation
40
Mycophenolic Acid
37
ruxolitinib
36
Tacrolimus
35
Melphalan
32
Busulfan
32
Biopsy
31
Cytarabine
30
Stem Cell Transplantation
27
Decitabine
27
Granulocyte Colony-Stimulating Factor
21
asciminib
19
decitabine and cedazuridine drug combination
18
Sirolimus
18
Peripheral Blood Stem Cell Transplantation
18
Injections
18
Thiotepa
17
Filgrastim
17
nilotinib
15
X-Rays
14
Methotrexate
14
Cyclosporine
14
Imatinib Mesylate
13
Magnetic Resonance Spectroscopy
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Association
×
Myeloid
×
1 year
×
Clear all
NCT06022016
2025-12-08
LUCID
Institut Claudius Regaud
Phase NA
Recruiting
910 enrolled